Benjamin F. Edwards & Company’s VanEck Biotech ETF BBH Stock Holding History

Benjamin F. Edwards & Company’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40	Closed	-$6K	–	1714
2019 Q4	$6K	Hold	40	–	–	﹤0.01%	1537
2019 Q3	$5K	Hold	40	–	–	﹤0.01%	1559
2019 Q2	$5K	Hold	40	–	–	﹤0.01%	1589
2019 Q1	$5K	Hold	40	–	–	﹤0.01%	1469
2018 Q4	$4K	Buy	+40	New	+$4.83K	﹤0.01%	1496
2016 Q1	–	Sell	-375	Closed	-$48K	–	1086
2015 Q4	$48K	Hold	375	–	–	0.01%	528
2015 Q3	$43K	Hold	375	–	–	0.01%	555
2015 Q2	$51K	Hold	375	–	–	0.01%	590
2015 Q1	$49K	Sell	375 -622	-62%	-$78.2K	0.01%	575
2014 Q4	$115K	Buy	997 +223	+29%	+$25.1K	0.03%	374
2014 Q3	$82K	Buy	774 +524	+210%	+$53K	0.02%	430
2014 Q2	$24K	Buy	+250	New	+$22.4K	0.01%	576

Other funds holding BBH

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Benjamin F. Edwards & Company's BBH Position: Q1 2020 in Review

Benjamin F. Edwards & Company sold out of VanEck Biotech ETF (BBH) in Q1 2020, closing a stake of 40 shares — an estimated $6K sold.

Benjamin F. Edwards & Company first reported a position in BBH in Q2 2014 and held it in 12 quarters. The position peaked at $115K in Q4 2014. 83 funds tracked by Wall St. Rank hold BBH as of Q1 2020.

Benjamin F. Edwards & Company reported no remaining VanEck Biotech ETF position as of Q1 2020 after selling out during the quarter.
Benjamin F. Edwards & Company sold 40 VanEck Biotech ETF shares in Q1 2020, an estimated $6K.
Benjamin F. Edwards & Company first reported a position in VanEck Biotech ETF in Q2 2014 and held it in 12 quarters.
Benjamin F. Edwards & Company's VanEck Biotech ETF position peaked at $115K in Q4 2014.
83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2020.

Based on Benjamin F. Edwards & Company's 13F filing for Q1 2020, filed 7 May 2020.